secwatch.observer — SEC 8-K summary
======================================

Issuer:     Novo Integrated Sciences, Inc. (—)
CIK:        0001138978
Form:       8-K
Filed at:   2023-04-21T23:59:59+00:00
Accession:  0001493152-23-013228
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Novo Integrated Sciences receives Nasdaq delisting notice for late Q2 FY2023 filing
--------------------------------------------------------------------------------

- On April 20, 2023, Nasdaq notified Company of non-compliance for not filing Feb. 28, 2023 Form 10-Q.
- November 2022 Form 10-Q also remains unfiled; all delinquent filings must be cured by May 29, 2023.
- Company intends to file both delinquent reports as soon as possible and update its compliance plan.
- Prior Form 10-K filed April 3, 2023; Nasdaq closed that deficiency on April 6, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1138978/000149315223013228/0001493152-23-013228-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1138978/000149315223013228/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-013228

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer